perform
prospect
studi
patient
chemotherapi
induc
febril
neutropenia
investig
diagnost
valu
lowdos
comput
tomographi
compar
standard
chest
radiographi
aim
compar
modal
detect
pulmonari
infect
explor
perform
lowdos
comput
tomographi
earli
detect
invas
fungal
diseas
lowdos
comput
tomographi
remain
blind
studi
consensu
diagnosi
fever
episod
made
expert
panel
use
refer
standard
includ
consecut
patient
first
day
febril
neutropenia
accord
consensu
diagnosi
patient
pulmonari
infect
sensit
specif
posit
predict
valu
neg
predict
valu
radiographi
lowdos
comput
tomographi
respect
uncorrect
mcnemar
show
statist
differ
p
mean
radiat
dose
lowdos
comput
tomographi
msv
four
includ
patient
diagnos
invas
fungal
diseas
radiograph
abnorm
suspect
invas
fungal
diseas
lowdos
comput
tomographi
scan
made
day
fever
compar
none
chest
radiograph
conclud
chest
radiographi
littl
valu
initi
assess
febril
neutropenia
day
detect
pulmonari
abnorm
lowdos
comput
tomographi
improv
detect
pulmonari
infiltr
seem
capabl
detect
invas
fungal
diseas
earli
stage
low
radiat
dose
neutropen
fever
one
import
complic
cancer
patient
critic
rapidli
local
infect
identifi
organ
involv
especi
fungal
infect
need
specif
treatment
approach
despit
standard
diagnost
workup
includ
chest
radiograph
cxr
microbiolog
screen
focu
identifi
patient
partli
explain
low
sensit
radiograph
diagnos
pulmonari
infect
neutropen
patient
acquir
cxr
respiratori
asymptomat
patient
febril
neutropenia
therefor
controversi
esmo
guidelin
recommend
perform
cxr
everi
neutropen
patient
fever
wherea
idsa
guidelin
suggest
use
patient
respiratori
sign
symptom
febril
neutropenia
substanti
part
infect
caus
invas
fungal
diseas
ifd
ifd
usual
present
pulmonari
infect
rare
visibl
cxr
therefor
often
miss
earli
phase
neutropen
fever
notabl
delay
start
appropri
treatment
neg
impact
clinic
outcom
order
improv
earli
detect
pulmonari
infiltr
febril
neutropenia
imag
tool
investig
altern
cxr
highresolut
comput
tomographi
hrct
improv
pulmonari
focu
detect
pulmonari
abnorm
found
neutropen
patient
persist
fever
hour
normal
cxr
furthermor
direct
initi
effect
antifung
treatment
earli
detect
halo
sign
hrct
imag
posit
effect
treatment
respons
surviv
case
ifd
emphas
import
earli
diagnosi
howev
due
cost
high
radiat
dose
approxim
msv
averag
hrct
scan
usual
incorpor
initi
febril
neutropenia
workup
anoth
imag
modal
could
use
evalu
febril
neutropenia
lowdos
ct
scan
ldct
ldct
perform
low
mean
radiat
dose
msv
without
use
contrast
two
studi
compar
ldct
cxr
patient
persist
febril
neutropenia
demonstr
increas
detect
pulmonari
abnorm
therefor
hypothes
ldct
alreadi
acquir
day
febril
neutropenia
would
improv
detect
pulmonari
infect
primari
aim
studi
compar
diagnost
perform
ldct
cxr
earli
detect
pulmonari
infiltr
secondari
aim
explor
perform
earli
ifd
detect
studi
approv
local
institut
review
board
approv
number
univers
medic
center
utrecht
written
inform
consent
obtain
patient
prospect
studi
conduct
haematolog
ward
univers
medic
center
utrecht
tertiari
care
oncolog
center
march
decemb
patient
febril
neutropenia
treat
intens
chemotherapi
haematolog
malign
receiv
autolog
myeloabl
allogen
stem
cell
transplant
sct
elig
inclus
febril
neutropenia
defin
singl
temperatur
measur
temperatur
hour
accompani
absolut
neutrophil
count
l
neutrophil
count
l
predict
declin
l
within
day
patient
exclud
case
known
focu
infect
unrel
lower
respiratori
tract
inclus
activ
possibl
probabl
fungal
infect
inclus
concomit
particip
clinic
research
subject
expos
addit
radiat
patient
could
particip
case
multipl
febril
episod
conform
neutropen
fever
diagnost
workup
start
accord
esmo
guidelin
patient
receiv
broad
spectrum
antibiot
imipenem
within
hour
patient
receiv
select
digest
tract
decontamin
start
chemotherapi
compris
ciprofloxacin
mg
fluconazol
mg
addit
ldct
scan
made
within
hour
start
fever
research
purpos
ldct
scan
remain
blind
studi
studi
patient
monitor
hour
without
fever
followup
period
cultur
result
avail
predefin
consensu
diagnosi
caus
fever
episod
made
expert
panel
consist
haematologist
microbiologist
radiologist
diagnost
workup
febril
neutropenia
diagnost
workup
includ
clinic
examin
cxr
microbiolog
screen
standard
microbiolog
screen
includ
evalu
urin
blood
cultur
respiratori
microbiolog
evalu
perform
case
suspect
pulmonari
infect
clinic
symptom
dyspnea
cough
sputum
product
oxygen
satur
level
respiratori
evalu
throat
swab
taken
test
viral
pathogen
pcr
pack
influenza
viru
respiratori
syncyti
viru
rsv
coronaviru
rhinoviru
pcr
pack
adenoviru
human
metapneumoviru
hmpv
parainfluenzaviru
type
bocaviru
mycoplasma
pneumonia
case
possibl
atyp
pneumonia
swab
addit
test
atyp
pathogen
pcr
pack
legionella
pneumonia
chlamydophila
pneumonia
chlamydophila
psitacci
coxiella
burnetti
sputum
avail
test
bacteria
gram
stain
cultur
fungal
pathogen
blancophor
stain
cultur
microbiolog
test
perform
judg
appropri
attend
physician
furthermor
serum
sampl
taken
twice
weekli
galactomannan
gm
test
end
inclus
fever
persist
day
routin
hrct
scan
acquir
detect
possibl
ifd
case
abnorm
suspect
fungal
pulmonari
infect
bronchoalveolar
lavag
bal
perform
bal
fluid
routin
test
bacteria
gram
stain
cultur
includ
haemophilu
influenza
fungal
pathogen
blancophor
stain
gm
microscopi
cultur
indic
bal
fluid
also
test
nocardia
cultur
mycobacteria
cultur
microscopi
pcr
pneumocysti
jiroveci
pneumonia
pcr
microscopi
viral
pathogen
pcr
pack
case
ifd
antifung
treatment
start
hrct
repeat
six
week
consensu
diagnosi
consensu
diagnosi
fever
episod
defin
accord
predefin
categori
either
pulmonari
infect
nonpulmonari
caus
fever
line
infect
mucos
infect
ie
sinus
unknown
focu
fever
combin
expert
panel
diagnosi
base
inform
obtain
clinic
chart
microbiolog
result
imag
result
cxr
hrct
hrct
avail
case
persist
day
fever
ldct
result
use
consensu
diagnosi
clinic
criteria
pulmonari
infect
includ
either
one
follow
symptom
cough
sputum
product
dyspnea
oxygen
satur
level
microbiolog
criteria
posit
cultur
pcr
bacteri
viral
fungal
pathogen
known
caus
pulmonari
infect
case
invas
aspergillosi
posit
gm
bal
serum
case
abnorm
imag
result
without
addit
clinic
microbiolog
criteria
consid
fals
posit
fungal
infect
classifi
either
possibl
probabl
proven
accord
revis
european
organ
research
treatment
cancermycosi
studi
group
eortcmsg
criteria
ifd
consid
rule
patient
recov
neutropen
fever
within
day
without
ever
receiv
mouldact
antifung
therapi
given
low
likelihood
spontan
recoveri
neutropenia
without
appropri
treatment
central
venou
cathet
infect
defin
criteria
adapt
dutch
surveil
network
nosocomi
infect
prezi
mucos
diagnos
base
clinic
radiolog
typhliti
criteria
clinic
criteria
includ
pain
swallow
nausea
vomit
abdomin
paincramp
diarrhea
physic
examin
absenc
posit
microbiolog
test
focu
infect
mainli
determin
judgment
attend
physician
combin
result
diagnost
workup
fever
unknown
origin
defin
fever
without
focu
etiolog
identifi
clinic
radiolog
microbiolog
examin
ldct
scan
made
inspir
lowest
achiev
radiat
dose
ldct
imag
acquir
tube
potenti
kvp
tube
currenttim
product
ma
ma
depend
patient
weight
use
ct
system
ict
philip
healthcar
best
netherland
tube
currenttim
product
ma
ma
ct
system
brillianc
philip
healthcar
best
netherland
end
studi
anonym
cxr
ldct
imag
first
independ
evalu
board
certifi
radiologist
radiolog
resid
involv
consensu
diagnosi
observ
use
standard
imag
score
tabl
tabl
second
cxr
ldct
imag
reanalys
one
two
observ
gave
posit
score
reevalu
perform
consensu
read
studi
exam
addit
histor
radiolog
imag
avail
prevent
falseposit
result
preexist
abnorm
primari
object
investig
whether
ldct
better
diagnost
tool
cxr
detect
pulmonari
infect
first
day
neutropen
fever
hypothes
ldct
could
increas
detect
rate
pulmonari
infiltr
cxr
unpublish
data
institut
consid
expect
incid
pulmonari
focu
infect
febril
neutropenia
expect
proport
discord
pair
twosid
test
alpha
power
sampl
size
patient
esteem
suffici
accord
power
calcul
base
mcnemar
test
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
test
calcul
use
conting
tabl
consensu
diagnosi
serv
refer
standard
uncorrect
mcnemar
test
appli
determin
differ
two
modal
pvalu
consid
signific
parametr
data
present
mean
standard
deviat
sd
nonparametr
data
median
rang
cohen
kappa
use
assess
inter
observ
agreement
defin
excel
good
moder
poor
ibm
spss
statist
softwar
version
ibm
somer
ny
usa
use
statist
analys
secondari
object
explor
perform
ldct
detect
pulmonari
lesion
indic
ifd
day
neutropen
fever
total
consecut
patient
recruit
march
decemb
five
patient
exclud
one
known
infect
unrel
respiratori
tract
inclus
one
result
activ
fungal
infect
one
ldct
acquir
hour
cxr
one
abl
undergo
ldct
scan
one
patient
cxr
avail
fig
baselin
characterist
patient
list
tabl
accord
consensu
diagnosi
patient
pulmonari
infect
ifd
possibl
probabl
rhinoviru
pneumonia
unknown
aetiolog
five
patient
pneumonia
underw
bronchoscopi
due
persist
fever
abnorm
hrct
patient
probabl
pathogen
identifi
evalu
balfluid
probabl
ifd
furthermor
patient
overal
nonspecif
mucos
like
caus
fever
four
patient
abdomin
imag
ct
perform
show
sign
typhliti
patient
focu
infect
found
consensu
diagnosi
result
list
tabl
mean
interv
cxr
ldct
hour
mean
radiat
dose
ldct
exam
msv
compar
chest
radiograph
averag
dose
posteroanterior
later
chest
radiograph
msv
none
patient
experienc
advers
event
result
ldct
scan
chest
radiographi
eight
cxr
indic
pneumonia
cxr
fals
posit
fals
neg
compar
consensu
diagnosi
tabl
result
sensit
specif
ppv
npv
cxr
none
cxr
suspect
ifd
thirteen
ldct
scan
suggest
pneumonia
compar
consensu
diagnosi
ldct
scan
fals
posit
fals
neg
sensit
specif
ppv
npv
respect
tabl
consensu
diagnosi
fals
posit
ldct
scan
phlebiti
case
fever
unknown
origin
hrct
scan
made
patient
fever
subsid
within
hour
receiv
broad
spectrum
antibiot
therefor
cxr
avail
imag
tool
consensu
meet
one
patient
fals
posit
ldct
respiratori
symptom
cough
howev
microbiolog
respiratori
evalu
neg
uncontrol
mcnemar
test
show
statist
signific
differ
proport
scan
posit
pulmonari
infect
cxr
ldct
p
primari
endpoint
interobserv
agreement
moder
cxr
ldct
cxr
ldct
respect
base
consensu
diagnosi
patient
cohort
classifi
either
probabl
n
possibl
n
ifd
diagnosi
probabl
ifd
base
posit
bal
gm
test
case
also
posit
serum
gm
test
patient
posit
bal
cultur
versicolor
four
patient
ifd
probabl
possibl
ldct
scan
suspect
ifd
first
day
fever
patient
abnorm
also
seen
hrct
perform
part
diagnost
workup
persist
fever
mean
day
later
ldct
fig
none
patient
diagnos
pulmonari
ifd
abnorm
cxr
first
day
fever
one
respiratori
sign
symptom
diagnosi
possibl
ifd
patient
neg
ldct
scan
base
abnorm
hrct
made
day
fever
serum
gm
valu
neg
bronchoscopi
perform
sever
thrombocytopenia
final
one
ldct
scan
abnorm
suspect
ifd
consid
fals
posit
fever
episod
classifi
fever
unknown
origin
conduct
prospect
studi
evalu
whether
pulmonari
focu
detect
would
improv
use
ldct
scan
instead
cxr
first
day
febril
neutropenia
establish
improv
detect
rate
radiograph
ldct
scan
primari
endpoint
met
result
lower
expect
incid
pulmonari
infect
studi
studi
underpow
nevertheless
demonstr
clinic
signific
increas
sensit
ldct
versu
cxr
detect
pulmonari
focu
day
neutropen
fever
limit
valu
cxr
standard
diagnost
procedur
line
previou
result
retrospect
studi
adult
sct
patient
evalu
none
cxr
perform
asymptomat
patient
febril
neutropenia
pulmonari
abnorm
indic
infect
detect
contrast
patient
respiratori
symptom
cxr
show
evid
pneumonia
studi
patient
true
posit
cxr
patient
respiratori
symptom
first
day
fever
two
previou
studi
compar
use
cxr
ldct
febril
neutropen
patient
present
studi
much
lower
mean
radiat
dose
msv
use
compar
msv
msv
studi
still
reconstruct
imag
diagnost
qualiti
patient
ldct
scan
previou
studi
acquir
use
older
gener
ct
system
slice
ct
scanner
patsio
et
al
slice
ct
scanner
kim
et
al
use
two
newer
gener
ct
system
slice
slice
newer
xray
tube
detector
softwar
result
potenti
reduc
radiat
dose
without
compromis
imag
qualiti
previou
studi
demonstr
ldct
increas
detect
rate
differ
sever
aspect
studi
patsio
et
al
compar
cxr
ldct
neutropen
aml
patient
alreadi
clinic
suspect
pneumonia
found
abnorm
imag
result
cxr
wherea
patient
abnorm
ldct
instead
focus
pulmonari
abnorm
suggest
pulmonari
infect
studi
also
includ
radiolog
sign
cardiac
failur
fluid
overload
might
explain
high
number
patient
abnorm
cxr
ldct
prospect
studi
kim
et
al
evalu
use
ldct
select
patient
persist
neutropen
fever
hour
regardless
presenc
respiratori
symptom
includ
patient
diagnos
pneumonia
differ
sensit
cxr
ldct
correctli
diagnos
infecti
pneumonia
littl
less
pronounc
studi
cxr
ldct
knowledg
first
studi
evalu
ldct
patient
febril
neutropenia
day
fever
demonstr
increas
sensit
improv
npv
perform
ldct
detect
pulmonari
infect
febril
neutropenia
import
detect
focu
infect
neutropen
fever
difficult
patient
often
undergo
sever
diagnost
test
uncertain
treatment
neg
side
effect
therefor
expect
everi
improv
diagnost
workup
eventu
lead
improv
patient
care
major
advantag
studi
complet
independ
assess
index
refer
test
ldct
cxr
independ
radiologist
short
time
interv
cxr
ldct
hour
howev
interobserv
agreement
moder
improv
move
forward
ldct
techniqu
point
evalu
ldct
imag
neutropen
popul
highrisk
develop
pulmonari
infect
requir
expertthorac
radiologist
may
yet
avail
everi
hospit
limit
studi
use
refer
standard
consensu
diagnosi
may
contribut
lower
test
perform
ldct
patient
cxr
imag
modal
avail
consensu
meet
sinc
hrct
perform
case
persist
fever
consid
low
sensit
cxr
popul
pulmonari
abnorm
could
miss
may
led
underestim
amount
patient
pneumonia
ldct
might
incorrectli
judg
fals
posit
furthermor
clinic
symptom
cough
sputum
product
dyspnea
alway
evid
bedridden
neutropen
patient
extens
microbiolog
evalu
respiratori
caus
fever
perform
upon
clinic
indic
might
therefor
perform
patient
abnorm
suspect
pulmonari
infect
ldct
sever
studi
report
limit
diagnost
yield
respiratori
microbiolog
evalu
neutropen
patient
lower
airway
infect
pathogen
identifi
sputum
cultur
often
avail
reveal
possibl
pathogen
less
case
bal
seem
diagnost
procedur
highest
yield
despit
low
detect
rate
probabl
pathogen
approxim
case
sensit
procedur
detect
ifd
howev
sinc
routin
perform
bal
initi
assess
fever
perform
due
invas
natur
consensu
diagnosi
use
studi
best
avail
option
compli
establish
guidelin
abl
identifi
probabl
pathogen
patient
pneumonia
case
possibl
ifd
exclud
consist
report
literatur
howev
establish
case
bacteri
pneumonia
may
explain
low
amount
patient
sputum
avail
cultur
cultureneg
possibl
treatment
respons
broad
spectrum
antibiot
result
defervesc
within
day
case
hrct
bal
perform
includ
heterogen
popul
patient
prolong
neutropenia
well
patient
shorter
neutropen
episod
could
effect
incid
pulmonari
infect
risk
develop
pneumonia
especi
ifd
increas
case
prolong
neutropenia
use
ldct
scan
detect
pulmonari
lesion
indic
ifd
day
neutropen
fever
seem
promis
fever
episod
classifi
either
possibl
probabl
ifd
patient
alreadi
abnorm
suspect
ifd
ldct
wherea
seen
cxr
importantli
one
patient
respiratori
sign
symptom
therefor
think
omit
chest
imag
patient
without
respiratori
symptom
lead
delay
diagnosi
ifd
incorpor
ldct
diagnost
workup
patient
neutropen
fever
increas
cost
compar
cxr
howev
initi
earli
target
treatment
ifd
may
reduc
overal
cost
exampl
reduc
length
hospit
stay
intens
care
unit
admitt
rate
amount
diagnost
procedur
requir
therefor
perform
ldct
patient
febril
neutropenia
might
still
costeffect
issu
evalu
futur
research
perform
cxr
initi
assess
febril
neutropenia
limit
valu
detect
pulmonari
abnorm
introduct
ldct
improv
detect
pulmonari
infiltr
clear
signal
ldct
scan
capabl
detect
invas
fungal
infect
earli
stage
therefor
use
ldct
initi
assess
febril
neutropenia
promis
evalu
larger
studi
power
ifd
detect
furthermor
would
interest
see
whether
ldct
could
replac
hrct
imag
tool
patient
suspect
ifd
order
decreas
radiat
exposur
